- Practice
- About 15 min
- 5 practice questions
Biotechnology in medicine: recombinant insulin and interferons
Define biotechnology and recombinant DNA, explain the structure of insulin and how human insulin is made in E. coli from pre-pro-insulin, and describe interferons and why yeast is used to produce them.
If something looks wrong, please tell us.
By the end of this lesson you can
- Define biotechnology, recombinant DNA and recombinant DNA technology.
- Describe the two chains of insulin and its role.
- Explain why animal insulin caused problems and how recombinant insulin is made.
- Describe interferons, their types and uses, and why yeast suits their production.
Before this chapter, revise DNA structure, protein synthesis and genetic engineering. Genetic engineering lets us take a gene from one organism and place it in the DNA of another of the same or a different species. The DNA so formed is recombinant DNA (rDNA), and the method is recombinant DNA technology. It has made it possible to produce hormones and other therapeutic proteins on a large scale.
What biotechnology means
Biotechnology is the application of scientific and engineering principles to the processing of materials by biological agents to provide goods and services; more simply, any technology that uses living systems or their products to make or modify products or processes. The textbook notes that the term was coined in 1919 by the Hungarian engineer Karl Ereky. Traditional activities such as making idli, curd, bread or wine use microbes, but they are not biotechnology in the modern sense, which rests on genetic engineering. Its four main areas of application are health care, agriculture, industry and the environment.
Insulin
Human insulin is made by the β cells of the islets of Langerhans in the pancreas. It has 51 amino acids in two polypeptide chains: chain A with 21 and chain B with 30, joined by disulphide bonds. Insulin lets cells take up and use glucose. Its deficiency causes diabetes mellitus, with a high blood glucose level and a group of symptoms that can be fatal if untreated. Banting and Best (1921) isolated insulin from the pancreas of a dog and showed that it worked against diabetes.
At first, insulin purified from the pancreas of pigs and cattle was used. Because animal insulin differs slightly in structure from human insulin, some patients developed allergic reactions. Production by rDNA technology began in the late 1970s, and recombinant insulin was approved for use in diabetes in 1982, under the trade name Humulin. It was the first pharmaceutical product of rDNA technology given to humans.
In the body, insulin is first made as pre-pro-insulin: a leader (signal) sequence, then chain B, a connecting C peptide, and chain A. The leader is removed after translation to give pro-insulin, and then the C peptide is cut out, leaving chains A and B joined by disulphide bonds.
Producing human insulin in bacteria
- Isolate the gene The human gene for insulin is obtained
- Cut the plasmid An E. coli plasmid is opened with a restriction enzyme
- Make recombinant DNA The insulin gene is joined into the plasmid
- Transform bacteria The recombinant plasmid is introduced into E. coli
- Grow in a fermentor Bacteria multiply and make the insulin chains
- Extract and purify The product is processed into active human insulin
Interferons
Interferons are antiviral proteins produced by mammalian cells when infected by viruses; they are species-specific. They were discovered by Alick Isaacs and Jean Lindenmann in 1957 and are classed as α, β and γ interferons. They make cells produce antiviral enzymes that inhibit viral replication. Extracting them from blood would need enormous volumes, so they are made by rDNA technology. The yeast Saccharomyces cerevisiae is more suitable than E. coli, because E. coli lacks the machinery for glycosylation (adding sugar groups) of proteins. According to the textbook, interferons are used in treating cancer, AIDS, multiple sclerosis, hepatitis C and herpes zoster, but their high production cost keeps them out of reach of many people.
The textbook also mentions Rosie (1997), the first transgenic cow, whose milk contained the human protein alpha-lactalbumin (about 2.4 g per litre) and was nutritionally more balanced for newborn babies than ordinary cow's milk.
Worked example 1: counting the amino acids in insulin
Chain A has 21 amino acids and chain B has 30. Total = 21 + 30 = 51. If pro-insulin also contains a C peptide of, say, 35 amino acids (a figure used only for practice), pro-insulin has 30 + 35 + 21 = 86 amino acids; removing the C peptide leaves 86 − 35 = 51, the size of mature insulin. This shows why the C chain must be excised for insulin to be complete and active.
Worked reasoning example 2: E. coli or yeast?
A company must choose a host for (a) insulin and (b) an interferon that needs sugar groups to work. Reasoning: (a) human insulin has been produced mainly in E. coli, which grows fast and cheaply. (b) A protein that must be glycosylated needs a eukaryotic host, because bacteria cannot add the sugar groups; yeast can. Choice: E. coli for insulin, Saccharomyces cerevisiae for the interferon.
Insulin: 51 amino acids, chain A 21, chain B 30, disulphide bonds; pre-pro-insulin → pro-insulin → insulin (leader and C peptide removed). Interferons: antiviral; made in yeast for glycosylation.
Key takeaways: recombinant DNA technology moves genes between organisms. Human insulin, with chains A (21) and B (30), is now made in bacteria, avoiding the allergies caused by animal insulin; it was the first rDNA drug. Interferons are species-specific antiviral proteins, best produced in yeast because it can glycosylate proteins.
Check your understanding
-
1. How many amino acids are present in the two chains of human insulin?
- Chain A 12, chain B 13
- Chain A 20, chain B 30
- Chain A 21, chain B 30
- Chain A 12, chain B 20
Show answer
Answer: C. Insulin has 51 amino acids: 21 in chain A and 30 in chain B, linked by disulphide bonds.
-
2. Why did insulin from pigs and cattle cause problems in some patients?
- It had no effect on blood glucose
- Its slightly different structure caused allergic reactions
- It contained bacteria
- It was made of DNA
Show answer
Answer: B. Animal insulin differs from human insulin in a few amino acids, enough to trigger allergic reactions in some diabetic patients.
-
3. Which part of pre-pro-insulin is removed to convert pro-insulin into insulin?
- Chain A
- Chain B
- The disulphide bonds
- The C peptide
Show answer
Answer: D. The leader sequence is removed first to form pro-insulin; then the C peptide joining chains A and B is cut out, leaving active insulin.
-
4. Recombinant interferons are better produced in Saccharomyces cerevisiae than in E. coli because:
- E. coli cannot glycosylate proteins
- yeast grows faster than all bacteria
- E. coli cannot take up plasmids
- interferons kill E. coli
Show answer
Answer: A. Interferons need glycosylation, and E. coli lacks that machinery. Yeast, a eukaryote, can add the sugar groups.
-
5. Assertion (A): Insulin was the first pharmaceutical product of rDNA technology given to humans. Reason (R): Interferons are species-specific antiviral proteins.
- Both A and R are true, and R is the correct explanation of A
- Both A and R are true, but R is not the correct explanation of A
- A is true, but R is false
- A is false, but R is true
Show answer
Answer: B. Both statements are true, but R is about interferons and says nothing about why insulin was the first rDNA drug. So R does not explain A.
Sign in to keep track of the lessons you finish.